Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma - Guo, Shuai; Bai, Xue; Liu, Yufei; Shi, Sai; Wang, Xuzhao; Zhan, Yong; Kang, Xianjiang; Chen, Yafei; An, Hailong (Frontiers in pharmacology, 2021)
Keywords: inhibitor; lung adenocarcinoma; molecular target; Pharmacology; silibinin; TMEM16A; TMEM16A; inhibitor; silibinin; molecular target; lung adenocarcinoma